These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15999146)

  • 1. Methylphenidate increases cortical excitability via activation of alpha-2 noradrenergic receptors.
    Andrews GD; Lavin A
    Neuropsychopharmacology; 2006 Mar; 31(3):594-601. PubMed ID: 15999146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo electrophysiological effects of methylphenidate in the prefrontal cortex: involvement of dopamine D1 and alpha 2 adrenergic receptors.
    Gronier B
    Eur Neuropsychopharmacol; 2011 Feb; 21(2):192-204. PubMed ID: 21146374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of methylphenidate on c-Fos expression in parvalbumin interneurons of juvenile rat frontal cortex].
    Zhang YC; Zhu XQ; Zhang XH
    Sheng Li Xue Bao; 2017 Aug; 69(4):378-384. PubMed ID: 28825095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors.
    Gamo NJ; Wang M; Arnsten AF
    J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1011-23. PubMed ID: 20855046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor and circuit mechanisms underlying differential procognitive actions of psychostimulants.
    Spencer RC; Berridge CW
    Neuropsychopharmacology; 2019 Sep; 44(10):1820-1827. PubMed ID: 30683912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms.
    Tseng KY; O'Donnell P
    J Neurosci; 2004 Jun; 24(22):5131-9. PubMed ID: 15175382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychostimulants and atomoxetine alter the electrophysiological activity of prefrontal cortex neurons, interaction with catecholamine and glutamate NMDA receptors.
    Di Miceli M; Gronier B
    Psychopharmacology (Berl); 2015 Jun; 232(12):2191-205. PubMed ID: 25572531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate action.
    Zhang CL; Feng ZJ; Liu Y; Ji XH; Peng JY; Zhang XH; Zhen XC; Li BM
    PLoS One; 2012; 7(12):e51910. PubMed ID: 23284812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of Acute or Chronic Methylphenidate Exposure Using Ex Vivo Neurochemistry and In Vivo Electrophysiology in the Prefrontal Cortex and Striatum of Rats.
    Di Miceli M; Derf A; Gronier B
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylphenidate amplifies long-term potentiation in rat hippocampus CA1 area involving the insertion of AMPA receptors by activation of β-adrenergic and D1/D5 receptors.
    Rozas C; Carvallo C; Contreras D; Carreño M; Ugarte G; Delgado R; Zeise ML; Morales B
    Neuropharmacology; 2015 Dec; 99():15-27. PubMed ID: 26165920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of methylphenidate on the membrane potential and current in neurons of the rat locus coeruleus.
    Ishimatsu M; Kidani Y; Tsuda A; Akasu T
    J Neurophysiol; 2002 Mar; 87(3):1206-12. PubMed ID: 11877494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylphenidate exerts dose-dependent effects on glutamate receptors and behaviors.
    Cheng J; Xiong Z; Duffney LJ; Wei J; Liu A; Liu S; Chen GJ; Yan Z
    Biol Psychiatry; 2014 Dec; 76(12):953-62. PubMed ID: 24832867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Administration of Methylphenidate (Ritalin) Affects Dopamine Release Differentially Between the Prefrontal Cortex and Striatum: A Microdialysis Study in the Monkey.
    Kodama T; Kojima T; Honda Y; Hosokawa T; Tsutsui KI; Watanabe M
    J Neurosci; 2017 Mar; 37(9):2387-2394. PubMed ID: 28154152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile methylphenidate modulates reward-related behaviors and cerebral blood flow by decreasing cortical D3 receptors.
    Andersen SL; Napierata L; Brenhouse HC; Sonntag KC
    Eur J Neurosci; 2008 Jun; 27(11):2962-72. PubMed ID: 18588536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with a clinically-relevant dose of methylphenidate alters NMDA receptor composition and synaptic plasticity in the juvenile rat prefrontal cortex.
    Urban KR; Li YC; Gao WJ
    Neurobiol Learn Mem; 2013 Mar; 101():65-74. PubMed ID: 23333502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine and norepinephrine receptors participate in methylphenidate enhancement of in vivo hippocampal synaptic plasticity.
    Jenson D; Yang K; Acevedo-Rodriguez A; Levine A; Broussard JI; Tang J; Dani JA
    Neuropharmacology; 2015 Mar; 90():23-32. PubMed ID: 25445492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Towards an understanding of the molecular mechanisms underlying the pharmacological treatments of attention deficit hyperactivity disorder].
    Castellanos FX; Acosta MT
    Rev Neurol; 2011 Mar; 52 Suppl 1():S155-60. PubMed ID: 21365598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of alpha 2A-adrenergic agonists in attention-deficit/hyperactivity disorder with or without oppositional symptoms.
    Stahl SM
    J Clin Psychiatry; 2010 Mar; 71(3):223-4. PubMed ID: 20331927
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential sensitivity to psychostimulants across prefrontal cognitive tasks: differential involvement of noradrenergic α₁ - and α₂-receptors.
    Berridge CW; Shumsky JS; Andrzejewski ME; McGaughy JA; Spencer RC; Devilbiss DM; Waterhouse BD
    Biol Psychiatry; 2012 Mar; 71(5):467-73. PubMed ID: 21890109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.